Literature DB >> 25852091

Cancer in a gerontological context.

Heidi D Klepin1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25852091      PMCID： PMC4542660          DOI： 10.1093/gerona/glv024

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN： 1079-5006            Impact factor:   6.053


× No keyword cloud information.
  5 in total

1.  Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer.

Authors:  Hanna K Sanoff; Allison M Deal; Janakiraman Krishnamurthy; Chad Torrice; Patrick Dillon; Jessica Sorrentino; Joseph G Ibrahim; Trevor A Jolly; Grant Williams; Lisa A Carey; Amy Drobish; Brittaney-Belle Gordon; Shani Alston; Arti Hurria; Karin Kleinhans; K Lenhard Rudolph; Norman E Sharpless; Hyman B Muss
Journal:  J Natl Cancer Inst       Date:  2014-03-28       Impact factor: 13.506

2.  Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry.

Authors:  Marije E Hamaker; Reinhard Stauder; Barbara C van Munster
Journal:  Oncologist       Date:  2014-08-28

3.  Future of cancer incidence in the United States: burdens upon an aging, changing nation.

Authors:  Benjamin D Smith; Grace L Smith; Arti Hurria; Gabriel N Hortobagyi; Thomas A Buchholz
Journal:  J Clin Oncol       Date:  2009-04-29       Impact factor: 44.544

4.  Current palliative chemotherapy trials in the elderly neglect patient-centred outcome measures.

Authors:  Marlies L van Bekkum; Barbara C van Munster; Peter L M Thunnissen; Carolien H Smorenburg; Marije E Hamaker
Journal:  J Geriatr Oncol       Date:  2014-10-03       Impact factor: 3.599

5.  Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration.

Authors:  Lilia Talarico; Gang Chen; Richard Pazdur
Journal:  J Clin Oncol       Date:  2004-11-15       Impact factor: 44.544
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.